As demand for 5G mobile phones increases, the vapor chamber (VC) is emerging to become a key component in 5G smartphone thermal management. Competition is keen among vapor chamber suppliers, and there ...

Series A Financing led by EcoR1 Capital, Jeito Capital and Syncona with continued support of strategic seed investors Vida Ventures, TPG and Two River Neogene’s proprietary technology platform ...

SANTA MONICA, Calif. & AMSTERDAM--(BUSINESS WIRE)--Neogene Therapeutics, Inc., a biotechnology company pioneering a new class of fully individualized T cell receptor (TCR) therapies to treat cancer, ...

NeoGene Tech, a Guangzhou-based Taiwanese thermal management solution provider, has in Q3 2022 supported Xiaomi to successfully launch its flagship 5G smartphone, Xiaomi 12S Ultra, with excellent ...

With the acquisition of Neogene Therapeutics this week and a CAR-T now in phase 1 courtesy of a Chinese deal, AstraZeneca hopes to add the first volumes to a planned “library” of off-the-shelf cell ...

A new immunotherapy biotech company that launched three years ago in Europe with backing from local biotech magnate Arie Belldegrun has set up its U.S. headquarters in Belldegrun’s former haunt, the ...

Nov 29 (Reuters) - AstraZeneca AZN.L said on Tuesday it would acquire Neogene Therapeutics, a developer of cell-based cancer treatments, for up to $320 million, as the London-listed drugmaker seeks to ...

Neogene aims to begin Phase I clinical studies in 2022. Neogene Therapeutics Inc. has raised $110 million in financing to advance the development of neo-antigen T cell therapies to treat various types ...

Figure 1: The nine locality intervals and number of localities (in parenthesis) analysed. Figure 2: Increase in hypsodonty is limited to common groups (present at over 25 per cent of localities within ...

The observed increase of body size in ungulates during the 20 million years before the Pleistocene is driven by the process of species selection, according to researchers. Bigger ungulate species ...

NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Neogene Therapeutics, Inc., a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, ...